Latest News and Press Releases

Phoenix, AZ, Oct. 14, 2024 (GLOBE NEWSWIRE) -- A recent paper by Shearston et al.,” Tampons as a source of exposure to metal(loid)s,” revealed their testing had detected trace amounts of 16 metals...

Austin, TX, USA, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Heavy Metal Testing Market Size, Trends and Insights By Type (Arsenic, Cadmium,...

  COMMUNIQUE DE PRESSE L'essai de phase 3 à venir avec l'ATO est plus robuste à la suite d'une nouvelle analyse post-hoc. Mont-Saint-Guibert, Belgique, le 18 juillet 2024 à 7h00 CEST – BIOSENIC...

Press Release The upcoming Phase 3 trial with ATO is more robust following a new post-hoc analysis. Mont-Saint-Guibert, Belgium, July 18, 2024, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris:...

COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE The adapted supply and commercialization conditions to better achieve the development of the first oral formulation of arsenic trioxide for the...

PRESS RELEASE – PRIVILEGED INFORMATION  The adapted supply and commercialization conditions to better achieve the development of the first oral formulation of arsenic trioxide for the treatment of...

COMMUNIQUE DE PRESSE Des données précliniques dans un modèle de souris transgénique montrent des effets bénéfiques sur divers symptômes cliniques analogues à ceux observés dans la sclérose...

PRESS RELEASE Preclinical data in a transgenic mouse model shows beneficial effects on various clinical symptoms analogous to those observed in human systemic sclerosis.Findings may further support...

 INFORMATION PRIVILEGIEE Les nouvelles données s'appuient sur l'analyse post-hoc de résultats antérieurs de phase 2 qui ont permis de repositionner le programme de BioSenic sur le trioxyde d'arsenic...

INSIDE INFORMATION New data builds on earlier findings from a post-hoc Phase 2 analysis that helped reposition BioSenic’s oral arsenic trioxide (OATO) program for pivotal trials.Data to be submitted...